Top Markets
#1 Black Phoenix Black Phoenix +21,534.66%
#2 Nesa Nesa +729.63%
#3 Kinesis Silver Kinesis Silver +54.95%
#4 BNB Attestation Service BNB Attestation Service +26.00%
#5 QuantixAI QuantixAI +24.05%
#6 EXOD EXOD +22.78%
#7 Pons Pons +20.03%
#8 Biconomy Biconomy +19.45%
#9 Derive Derive +18.54%
#10 Cash Cat Cash Cat +16.88%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Gedeon Richter PLC Gedeon Richter PLC

Gedeon Richter PLC

GEDSF
株式のランク #3863
Gedeon Richter Plc is a company focused on the development and manufacturing of... Gedeon Richter Plc is a company focused on the development and manufacturing of pharmaceutical products. Its operations are organized into three primary divisions: Pharmaceuticals, Wholesale & Retail, and Other. The Pharmaceutical segment covers all aspects from the research and development of new drugs and their production, through to their sales and marketing. The Wholesale & Retail division is responsible for distributing the company's products to consumers via its network of affiliated companies and pharmacies across various regional markets. The Other segment includes services provided by group members that support marketing and sales activities. The company was established in 1901 by Gedeon Richter and is headquartered in Budapest, Hungary.
株価
$24.85
最終同期: 2026-08-21
時価総額
$4.54B
変化（1日）
0.00%
変化（1年）
0.00%
国
HU
取引 Gedeon Richter PLC (GEDSF)

カテゴリー

Healthcare
Gedeon Richter PLC（GEDSF）の収益
Aug 2026 時点の収益 TTM: 0
Gedeon Richter PLC の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Gedeon Richter PLC の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $4.55B -
HK